Pfizer to start distributing 6 million Paxlovid therapies

The world-renowned Pfizer is ready to provide access to Paxlovid for 132 developing countries. The pharmaceutical corporation first announced treatment delivery in May, as part of the Global Fund's Covid-19 Response Mechanism to provide medicines, tests and equipment to fight coronavirus infection in low-and-middle-income countries. 

"This agreement with the Global Fund is considered a key milestone with patients from developing states having equal access to treatment," noted Albert Burla, chairman and CEO of Pfizer, during a press release.

All developing countries, being the Global Fund, are expected to receive Paxlovid. Treatment costs, in turn, would be calculated through tiered pricing. So that Pfizer is to set a nonprofit price for low-and-middle-income countries. However, paying for medicine by developed nations is likely to be higher. The cost of drugs, on the other hand, hasn't been disclosed yet.

The Global Fund agreement is part of Pfizer's plan to expand Paxlovid treatments worldwide.